pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
ecallantide
Kalbitor (ecallantide)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Dyax Corp
0 catalysts
Marketed
econazole nitrate
Ecoza (econazole nitrate)
Tinea Pedis (Athlete Foot)
Resilia Pharmaceuticals Inc
0 catalysts
Phase 3
ecopipam hydrochloride
Tourette Syndrome
Emalex Biosciences Inc
0 catalysts
Marketed
← prev
page 173 of 231
next →
131
Pain89
Neurology1
ecothiopate iodide
Phospholine Iodide (ecothiopate iodide [INN])
Accommodative Esotropia
Fera Pharmaceuticals LLC
0 catalysts
Marketed
eculizumab
Soliris (eculizumab)
Paroxysmal Nocturnal Hemoglobinuria
Alexion Pharmaceuticals Inc
0 catalysts
Marketed
edaravone
Radicava ORS (edaravone)
Amyotrophic Lateral Sclerosis
$SGIOFSHIONOGI & CO LTD
0 catalysts
Marketed
edetate calcium disodium
Edetate Calcium Disodium (edetate calcium disodium)
Lead Poisoning
Casper Pharma LLC
0 catalysts
Preclinical
edodekin alfa SR
edodekin alfa
Pancreatic Cancer
TherapyX Inc
0 catalysts
Marketed
edoxaban tosylate
Savaysa (edoxaban tosylate)
Atrial Fibrillation
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
efarindodekin alfa
efarindodekin alfa[INN]
Cervical Cancer
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
efavirenz
Efavirenz (efavirenz)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Camber Pharmaceuticals Inc
0 catalysts
Marketed
efbemalenograstim alfa LA
Ryzneuta (efbemalenograstim alfa)
Chemotherapy Induced Neutropenia
Acrotech Biopharma Inc
0 catalysts
Phase 2
efdoralprin alfa
efdoralprin alfa [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$SNYSanofi
0 catalysts
pre_registration
efgartigimod alfa
Vyvgart (efgartigimod alfa)
Myasthenia Gravis
IgG receptor FcRn large subunit p51
$ARGXARGENX SE
0 catalysts
Phase 2
efgitasialase alfa
Breast Cancer
Palleon Pharmaceuticals Inc
0 catalysts
Phase 2
efineptakin alfa
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
NeoImmuneTech Inc
0 catalysts
Phase 2
efinopegdutide
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Glucagon receptorGlucagon-like peptide 1 receptor
$MRKMerck & Co., Inc.
0 catalysts
Marketed
eflapegrastim
Rolvedon (eflapegrastim-xnst)
Chemotherapy Induced Neutropenia
Spectrum Pharmaceuticals Inc
0 catalysts
Phase 3
eflornithine
eflornithine [INN]
Anaplastic Astrocytoma
Orbus Therapeutics Inc
0 catalysts
Phase 3
efmirenpase alfa
efmirenpase alfa [INN]
Arterial Calcification
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Phase 2
efocipegtrutide
efocipegtrutide [INN]
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 2
efpegerglucagon
efpegerglucagon [INN]
Hyperinsulinemia
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 3
efruxifermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Akero Therapeutics Inc
0 catalysts
Phase 3
efsudenermin alfa
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EspeRare Foundation
0 catalysts
Phase 3
eftilagimod alfa
eftilagimod alfa [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$IMMPIMMUTEP Ltd
0 catalysts
Phase 3
efzimfotase alfa
Hypophosphatasia
Alexion Pharmaceuticals Inc
0 catalysts
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)
$ATYRaTYR PHARMA INC
0 catalysts
Phase 2
egalognastat
egalognastat [INN]
Progressive Supranuclear Palsy
Grupo Ferrer Internacional SA
0 catalysts
Marketed
elacestrant hydrochloride
Orserdu (elacestrant hydrochloride)
Metastatic Breast Cancer
Estrogen receptor
A. Menarini Industrie Farmaceutiche Riunite Srl
0 catalysts
Marketed
eladocagene exuparvovec
Kebilidi (eladocagene exuparvovec)
Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency
$PTCPTC INC.
0 catalysts